Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype?
NCT00269464 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2007-12-27
Summary
Evaluating the prevalence and characteristics of obsessive-compulsive (OC) symptoms in patients with chronic schizophrenia
Conditions
- Schizophrenia
- Obsessive Compulsive Disorder
Sponsors & Collaborators
-
Sheba Medical Center
lead OTHER_GOV
Principal Investigators
-
Joseph Zohar, MD · Tel Aviv University
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 2007-03-31
More Related Trials
-
A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia
NCT04510298 ·Status: COMPLETED ·Phase: PHASE1
-
Obsessive-Compulsive Disorder: Insight, Trauma, and Links to Schizophrenia Spectrum Disorders
NCT07092826 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia
NCT03471013 ·Status: TERMINATED
-
Normal and Abnormal ERP During ToM and Emotional Conflicts in Schizophrenia
NCT02896374 ·Status: COMPLETED ·Phase: NA
-
Administrating Oxytocin to Treat Treatment Schizophrenia and Schizo-affective Patients
NCT01598623 ·Status: UNKNOWN ·Phase: PHASE2
-
Mindfulness, Empathy and the Oxytocinergic System in Persons With Schizophrenia
NCT05491486 ·Status: UNKNOWN ·Phase: NA
-
Association Between Schizophrenia and Cancer
NCT00419016 ·Status: COMPLETED
-
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
NCT06963034 ·Status: RECRUITING ·Phase: PHASE3
-
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014 ·Status: UNKNOWN
-
Morphological, Structural and Functional Neural Substrates of Quality of Life in Schizophrenia
NCT01295411 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia
NCT00063297 ·Status: COMPLETED ·Phase: PHASE2
-
An Integrated Neurophysiological Approach Toward the Early Detection of Psychiatric Disorders
NCT06886945 ·Status: RECRUITING
-
Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia
NCT00654706 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia
NCT02874560 ·Status: COMPLETED
-
Exploring the Effect of Rumination-Focused Cognitive Behaviour Therapy in Patients With Schizophrenia
NCT04442893 ·Status: COMPLETED ·Phase: NA
-
Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics Medication
NCT00698295 ·Status: UNKNOWN
-
Treatment Response to Rehabilitation in Patients With Schizophrenia
NCT00063336 ·Status: COMPLETED ·Phase: NA
-
Oculomotor and Spatial Cognition Deficits in Schizophrenia
NCT00931996 ·Status: TERMINATED ·Phase: NA
-
Response Shift and Quality of Life in Patients Suffering From Schizophrenia and Their Caregivers
NCT02868307 ·Status: UNKNOWN ·Phase: NA
-
Trial of Cognitive Behavioral Therapy for Schizophrenia
NCT00300651 ·Status: UNKNOWN ·Phase: PHASE3
-
Sustained Attention Abilities in Schizophrenia
NCT02388607 ·Status: UNKNOWN
-
Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia
NCT00893256 ·Status: COMPLETED ·Phase: PHASE4
-
Waist Circumference Measurements in Schizophrenic Patients
NCT01243034 ·Status: COMPLETED
-
Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
NCT00932529 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of a Helplessness and Recovery of an Empowerment Intervention on People Diagnosed With Schizophrenia: Findings From a Randomized Controlled Trial
NCT02968667 ·Status: COMPLETED ·Phase: PHASE2